Red clover extract ameliorates dyslipidemia in streptozotocin-induced diabetic C57BL/6 mice by activating hepatic PPARα

Phytotherapy Research

Volumn 26, Issue 6, 2012, Pages 860-864

  Qiu, Longxin ^a   Ye, Hong ^a   Chen, Limei ^a   Hong, Yamin ^a   Zhong, Fojin ^a   Zhang, Tingting ^a  

^a LONGYAN UNIVERSITY   (China)

Author keywords

biochanin A; blood lipids; diabetes; formononetin; peroxisome proliferator activated receptor ; red clover extract

Indexed keywords

APOLIPOPROTEIN A5; APOLIPOPROTEIN C3; BIOCHANIN A; FORMONONETIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; RED CLOVER EXTRACT; STREPTOZOCIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; APOLIPOPROTEIN A5 GENE; APOLIPOPROTEIN C3 GENE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DOWN REGULATION; DRUG EFFECT; DYSLIPIDEMIA; GENE; GENE EXPRESSION REGULATION; GLUCOSE BLOOD LEVEL; MALE; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; TRANSCRIPTION REGULATION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEIN C-III; APOLIPOPROTEINS; BLOOD GLUCOSE; CHOLESTEROL, LDL; DIABETES MELLITUS, EXPERIMENTAL; DYSLIPIDEMIAS; GENE EXPRESSION REGULATION; GENISTEIN; HYPOGLYCEMIC AGENTS; ISOFLAVONES; LIVER; MALE; MICE; MICE, INBRED C57BL; PHYTOTHERAPY; PLANT EXTRACTS; PPAR ALPHA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STREPTOZOCIN; TRIFOLIUM; TRIGLYCERIDES;

MUS; TRIFOLIUM PRATENSE;

EID: 84861810610     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.3641     Document Type: Article

References (30)

1. Asgary S, Moshtaghian J, Naderi G, et al., 2007. Effects of dietary red clover on blood factors and cardiovascular fatty streak formation in hypercholesterolemic rabbits. Phytother Res 21: 768-770.
2. Auwerx J, Schoonjans K, Fruchart JC, Staels B,. 1996. Transcriptional control of triglyceride metabolism: fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR. Atherosclerosis 124 (Suppl): S29-S37.
3. Beck V, Rohr U, Jungbauer A,. 2005. Phytoestrogens derived from red clover: an alternative to estrogen replacement therapy? J Steroid Biochem Mol Biol 94: 499-518.
4. Bhathena SJ, Velasquez MT,. 2002. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76: 1191-1201.
5. Dang ZC, Audinot V, Papapoulos SE, Boutin JA, Lowik CW,. 2003. Peroxisome proliferator-activated receptor gamma (PPARgamma) as a molecular target for the soy phytoestrogen genistein. J Biol Chem 278: 962-967.
6. Decochez K, Rippley RK, Miller JL, et al., 2006. A dual PPAR alpha/gamma agonist increases adiponectin and improves plasma lipid profiles in healthy subjects. Drugs R&D 7: 99-110.
7. Djouadi F, Weinheimer CJ, Saffitz JE, et al., 1998. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice. J Clin Invest 102: 1083-1091.
8. Geller SE, Studee L,. 2006. Soy and red clover for mid-life and aging. Climacteric 9: 245-263.
9. Goldstein BJ, Rosenstock J, Anzalone D, Tou C, Ohman KP,. 2006. Effect of tesaglitazar, a dual PPAR alpha/gamma agonist, on glucose and lipid abnormalities in patients with type 2 diabetes: a 12-week dose-ranging trial. Curr Med Res Opin 22: 2575-2590.
10. Guo L, Tabrizchi R,. 2006. Peroxisome proliferator-activated receptor gamma as a drug target in the pathogenesis of insulin resistance. Pharmacol Ther 111: 145-173.
11. Haines, C, James A, Sahota D, et al., 2006. Comparison between phytoestrogens and estradiol in the prevention of atheroma in ovariectomized cholesterol-fed rabbits. Climacteric 9: 430-436.
12. Hisatomi M, Hayakawa T, Hidaka H, Niki I,. 1997. Modulation of tyrosine kinase activity has multiple actions on insulin release from the pancreatic beta-cell: studies with lavendustin A. Jpn J Pharmacol 74: 203-208.
13. Howes JB, Sullivan D, Lai N, et al., 2000. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolaemia. Atherosclerosis 152: 143-147.
14. Kota BP, Huang TH, Roufogalis BD,. 2005. An overview on biological mechanisms of PPARs. Pharmacol Res 51: 85-94.
15. Lautamaki R, Nuutila P, Airaksinen KE, et al., 2006. The effect of PPARgamma-agonism on LDL subclass profile in patients with type 2 diabetes and coronary artery disease. Rev Diabet Stud 3: 31-38.
16. Lee JS,. 2006. Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocin-induced diabetic rats. Life Sci 79: 1578-1584.
17. Lefebvre P, Chinetti G, Fruchart JC, Staels B,. 2006. Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis. J Clin Invest 116: 571-580.
18. Lukaczer D, Darland G, Tripp M, et al., 2005. Clinical effects of a proprietary combination isoflavone nutritional supplement in menopausal women: a pilot trial. Altern Ther Health Med 11: 60-65.
19. Mezei O, Banz WJ, Steger RW, Peluso MR, Winters TA, Shay N,. 2003. Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. J Nutr 133: 1238-1243.
20. Mueller M, Hobiger S, Jungbauer A,. 2010. Red clover extract: a source for substances that activate peroxisome proliferator-activated receptor alpha and ameliorate the cytokine secretion profile of lipopolysaccharide-stimulated macrophages. Menopause 17: 379-387.
21. Ohno T, Kato N, Ishii C, et al., 1993. Genistein augments cyclic adenosine 3'5'-monophosphate(cAMP) accumulation and insulin release in MIN6 cells. Endocr Res 19: 273-285.
22. Qiu L, Wu X, Chau JF, et al., 2008. Aldose reductase regulates hepatic peroxisome proliferator-activated receptor alpha phosphorylation and activity to impact lipid homeostasis. J Biol Chem 283: 17175-17183.
23. Schult TM, Ensrud KE, Blackwell T, Ettinger B, Wallace R, Tice JA,. 2004. Effect of isoflavones on lipids and bone turnover markers in menopausal women. Maturitas 48: 209-218.
24. Shen P, Liu MH, Ng TY, Chan YH, Yong EL,. 2006. Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARalpha, PPARgamma, and adipocyte differentiation in vitro. J Nutr 136: 899-905.
25. Sorenson RL, Brelje TC, Roth C,. 1994. Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion. Endocrinology 134: 1975-1978.
26. Taku, K, Umegaki K, Sato Y, Taki Y, Endoh K, Watanabe S,. 2007. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 85: 1148-1156.
27. Uesugi T, Fukui Y, Yamori Y,. 2002. Beneficial effects of soybean isoflavone supplementation on bone metabolism and serum lipids in postmenopausal japanese women: a four-week study. J Am Coll Nutr 21: 97-102.
28. Vedavanam K, Srijayanta S, O'Reilly J, Raman A, Wiseman H,. 1999. Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother Res 13: 601-608.
29. Vu-Dac N, Gervois P, Jakel H, et al., 2003. Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activators. J Biol Chem 278: 17982-17985.
30. Wangen KE, Duncan AM, Xu X, Kurzer MS,. 2001. Soy isoflavones improve plasma lipids in normocholesterolemic and mildly hypercholesterolemic postmenopausal women. Am J Clin Nutr 73: 225-231.